WG
CYTK icon

Winton Group’s Cytokinetics CYTK Stock Holding History

Winton Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,159
Closed -$930K – 791
2025
Q2 		$930K Buy
28,159
+3,904
+16% +$136K 0.05% 453
2025
Q1 		$975K Buy
24,255
+5,250
+28% +$241K 0.06% 432
2024
Q4 		$894K Buy
19,005
+9,210
+94% +$478K 0.06% 372
2024
Q3 		$517K Sell
9,795
-8,354
-46% -$466K 0.04% 438
2024
Q2 		$983K Buy
+18,149
New +$1.1M 0.07% 250
2024
Q1 		– Sell
-17,596
Closed -$1.47M – 663
2023
Q4 		$1.47M Buy
+17,596
New +$637K 0.11% 145
2023
Q2 		– Sell
-11,380
Closed -$400K – 850
2023
Q1 		$400K Buy
11,380
+1,000
+10% +$40.8K 0.02% 757
2022
Q4 		$476K Buy
10,380
+3,403
+49% +$146K 0.03% 648
2022
Q3 		$338K Sell
6,977
-297
-4% -$14.3K 0.02% 757
2022
Q2 		$286K Buy
+7,274
New +$293K 0.02% 815
2022
Q1 		– Sell
-6,868
Closed -$313K – 995
2021
Q4 		$313K Buy
+6,868
New +$265K 0.02% 816

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Winton Group's CYTK Position: Q3 2025 in Review

Winton Group sold out of Cytokinetics (CYTK) in Q3 2025, closing a stake of 28,159 shares — an estimated $930K sold.

Winton Group first reported a position in CYTK in Q4 2021 and held it in 11 quarters. The position peaked at $1.47M in Q4 2023. 380 funds tracked by Wall St. Rank hold CYTK as of Q3 2025.

  • Winton Group reported no remaining Cytokinetics position as of Q3 2025 after selling out during the quarter.
  • Winton Group sold 28,159 Cytokinetics shares in Q3 2025, an estimated $930K.
  • Winton Group first reported a position in Cytokinetics in Q4 2021 and held it in 11 quarters.
  • Winton Group's Cytokinetics position peaked at $1.47M in Q4 2023.
  • 380 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2025.

Based on Winton Group's 13F filing for Q3 2025, filed 13 Nov 2025.